Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
REGN News
A pharmaceutical company that specializes in making DNA-based research agreed to buy 23andMe out of bankruptcy, averting a worst-case scenario as the genetic da...
...
Regeneron Pharmaceuticals Inc. REGN announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $2...
Analyst ratings
79%
of 28 ratingsMore REGN News
Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company...
DNA-testing company 23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. Ea...
Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market...
Regeneron Pharmaceuticals (NASDAQ:REGN) will buy substantially all assets of genetic testing firm 23andMe (OTC:MEHCQ) for a purchase price of $256M. 23andMe fi...
Regeneron (REGN) has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe (ME) Holding. Regeneron intends t...
Terence Flynn, an analyst from Morgan Stanley, maintained the Buy rating on Regeneron (REGN – Research Report). The associated price target remains the same wit...
Analysts are intrested in these 5 stocks: ( (MRK) ), ( (REGN) ), ( (CLRB) ), ( (HUMA) ) and ( (FL) ). Here is a breakdown of their recent ratings and the ration...